“…In summary, CES (Carron, Behr, & Ori, 2013; Chabbouh et al, 2005; Merino‐Urrutia et al, 2018; Moussa et al, 2006; Ozgen, Baykan, Dogan, Konya, & Pamir, 2004; Shields, Iyer, Zhang, & Shields, 2018; Takasu et al, 2010; Vianna et al, 2001) and transient radicular irritation syndrome (TNS) (Al‐Nasser, Negre, & Hubert, 2002; Evron et al, 2007; Salazar, Bogdanovich, Adalia, Chabás, & Gomar, 2001; Ya‐Deau, Liguori, & Zayas, 2005; Zaric, Christiansen, Pace, & Punjasawadwong, 2005) are rare but still prevalent complications of spinal subarachnoid block, and their exact cause remains unclear. All previously proposed hypotheses have been losing support, and the effects have been described as occurring with most LA agents: lidocaine (Gerancher, 1997; Loo & Irestedt, 1999; Newman et al, 1997; Salmela, Aromaa, & Cozanitis, 1996; Schneider et al, 1993; Tarkkila et al, 1995), tetracaine (Sumi et al, 1996; Vianna et al, 2001), isobaric bupivacaine (Moussa et al, 2006; Tarkkila et al, 1996), hyperbaric bupivacaine (Chabbouh et al, 2005; Keld, Hein, Dalgaard, Krogh, & Rodt, 2000), levobupivacaine (Carron et al, 2013), mepivacaine (Liguori et al, 1998; Salazar et al, 2001; Ya‐Deau et al, 2005), ropivacaine (Al‐Nasser et al, 2002; Ganapathy, Sandhu, Stockall, & Hurley, 2000), and prilocaine (Martínez‐Bourio et al, 1998). Hyperosmolarity (Ganapathy et al, 2000; Hampl, Schneider, Thorin, et al, 1995; Hampl, Schneider, Ummenhofer, & Drewe, 1995) has not been shown to be causal, and the use of more dilute concentrations did not prevent this complication (Arndt & Downey, 2002; Evron et al, 2007; Hampl et al, 1996; Pollock, Liu, Neal, & Stephenson, 1999; Sakura, Chan, Ciriales, & Drassner, 1995; Salazar et al, 2001).…”